Clinical Trial Update: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) [Phase 2]

View source ↗

Summary

Phase 2 study of ARC-520 for chronic hepatitis B with or without other drugs was terminated; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis D

Drugs mentioned

• ARC-520

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Hepatitis B, Hepatitis D | Phase 2 | Status: TERMINATED | Results posted: 2019-04-12